Immunogenic-cell-killing and immunosuppression-inhibiting nanomedicine

Combining chemo-therapeutics with immune checkpoint inhibitors facilitates killing cancer cells and activating the immune system through inhibiting immune escape. However, their treatment effects remain limited due to the compromised accumulation of both drugs and inhibitors in certain tumor tissues...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Gao, Di, Liu, Yan, Guo, Xiaoqing, Chen, Shuojia, Zeng, Li, Ma, Jinxuan, Zhang, Xingcai, Tian, Zhongmin, Yang, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689277/
https://www.ncbi.nlm.nih.gov/pubmed/33294730
http://dx.doi.org/10.1016/j.bioactmat.2020.11.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689277/
https://www.ncbi.nlm.nih.gov/pubmed/33294730
http://dx.doi.org/10.1016/j.bioactmat.2020.11.016

Ejemplares similares